Respiratory Infections

In a wounded mouse model concurrently infected with influenza A, investigators observed that the innate immune system prioritized responding to the lung infection, delaying wound healing.

New recommendations from the CDC's Advisory Committee on Immunization Practices reveal that health care providers have the intranasally-administered live attenuated influenza vaccine (LAIV) among their arsenal of available vaccines for the 2018-2019 flu season.

Health care providers, especially those practicing in the southern United States, should consider angiostrongyliasis in patients with eosinophilic meningitis.

The incidence of Neisseria meningitidis serogroup W is rising in Georgia.

Julie Ann Justo, PharmD, MS, BCPS-AQ ID, provides an example of how institution-specific information can be used to generate a customized risk score.

The PDUFA action date has been set for February 13, 2019.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

The FDA advisory committee voted 17 to 1 in favor of omadacycline for treatment of ABSSSI and 14 to 4 for the treatment of CABP.

If approved, ALIS will be the first and only therapy available in the United States that will be specifically indicated for the treatment of patients with NTM lung disease caused by MAC.

Investigators report that the duration of viral shedding of influenza A in obese adults was 42% longer than nonobese adults.

New research suggests 4 months of rifampin produced higher rates of adherence than 9 months of isoniazid in individuals with latent tuberculosis.

With vaccine efficacy during the 2017–2018 flu season under question, a novel antiviral agent may provide a solution.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Gram-negative organisms are showing up at higher rates in seriously ill pneumonia patients. What are the best antibiotics to prescribe, given the real risk of death and the need to avoid contributing to drug resistance?

A recent report shows that patients receiving eculizumab remain extremely susceptible to meningococcal disease, including from nongroupable Neisseria meningitidis strains, despite being vaccinated against the disease.

Genentech has announced that baloxavir marboxil met primary objective in the phase 3 CAPSTONE-2 study for individuals with a high risk of complications from influenza.

New data indicate that urgent care centers prescribed antibiotics for 45.7% patients with respiratory infections associated with inappropriate antibiotic prescribing.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

In case you missed them, we’ve compiled the top 5 infectious disease articles from this past week.

A new study observed that the type of pertussis vaccine used to prime the immune system in childhood has a lasting effect on an individual’s future immune response.

Johns Hopkins Hospital evacuates over tuberculosis concerns.

Stay up-to-date on the latest infectious disease news by reading the top 5 articles of the week.

CDC researchers say that some influenza respiratory infections may be originating in the eye, and thus, more research is needed pertaining to ocular transmission.

New CDC recommendations include the use of 3HP in children and individuals with LTBI who have HIV infection, including AIDS.

Doctors are prescribing antibiotics too often for viral acute respiratory infections.